Matthew Call

Insider Reports History

Entity
Individual
Location
C/O Iteos Therapeutics, Inc., 139 Main Street, Cambridge, MA
Signature
/s/ Adi Osovsky, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Matthew Call:

Stock Role Class Num Shares Value Price $ Report Date Ownership
iTeos Therapeutics, Inc. Chief Operating Officer Common Stock 138K $1.15M $8.37 Dec 5, 2023 Direct
iTeos Therapeutics, Inc. Chief Operating Officer Stock Option (Right to Buy) 225K Mar 7, 2024 Direct

Insider Reports Filed by Matthew Call

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ITOS iTeos Therapeutics, Inc. Mar 7, 2024 1 $0 4 Mar 8, 2024 Chief Operating Officer
ITOS iTeos Therapeutics, Inc. Dec 5, 2023 1 $0 4 Dec 7, 2023 Chief Operating Officer
ITOS iTeos Therapeutics, Inc. Mar 28, 2023 2 $119K 4 Mar 29, 2023 Chief Operating Officer
ITOS iTeos Therapeutics, Inc. Mar 9, 2023 1 $0 4 Mar 10, 2023 Chief Operating Officer
ITOS iTeos Therapeutics, Inc. Mar 11, 2022 1 $0 4 Mar 14, 2022 Chief Operating Officer
ITOS iTeos Therapeutics, Inc. Jul 30, 2021 2 $158K 4 Aug 5, 2021 Chief Operating Officer
ITOS iTeos Therapeutics, Inc. Jun 24, 2021 1 $0 4 Jun 25, 2021 Chief Operating Officer